{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:51:33Z","timestamp":1760205093487,"version":"3.37.3"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T00:00:00Z","timestamp":1604534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,2,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>As neutropenic patients with haematological cancer are not typically included in randomized controlled trials (RCTs) of candidaemia, there is low quality of evidence regarding the management of this common opportunistic mycosis in this patient population, which is at high risk for poor outcomes. Herein we identify the gaps in knowledge that are not addressed by the modern RCTs and candidaemia guidelines, and outline some considerations for the future clinical research agenda in candidaemia\/invasive candidiasis in haematological patients.<\/jats:p>","DOI":"10.1093\/jac\/dkaa446","type":"journal-article","created":{"date-parts":[[2020,10,6]],"date-time":"2020-10-06T19:15:48Z","timestamp":1602011748000},"page":"543-546","source":"Crossref","is-referenced-by-count":9,"title":["Knowledge gaps in candidaemia\/invasive candidiasis in haematological cancer patients"],"prefix":"10.1093","volume":"76","author":[{"given":"Arnaldo Lopes","family":"Colombo","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3784-3266","authenticated-orcid":false,"given":"Caroline","family":"Agnelli","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Escola Paulista de Medicina, Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios P","family":"Kontoyiannis","sequence":"additional","affiliation":[{"name":"Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,11,5]]},"reference":[{"key":"2021021208580891800_dkaa446-B1","doi-asserted-by":"crossref","first-page":"e344\u201356","DOI":"10.1016\/S1473-3099(17)30304-3","article-title":"Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer","volume":"17","author":"Colombo","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2021021208580891800_dkaa446-B2","doi-asserted-by":"crossref","first-page":"5471","DOI":"10.1200\/JCO.2007.12.3851","article-title":"Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis","volume":"25","author":"Robenshtok","year":"2007","journal-title":"J Clin Oncol"},{"key":"2021021208580891800_dkaa446-B3","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s00134-017-4743-y","article-title":"The risk and clinical outcome of candidemia depending on underlying malignancy","volume":"43","author":"Lortholary","year":"2017","journal-title":"Intensive Care Med"},{"key":"2021021208580891800_dkaa446-B4","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1093\/jac\/dkv087","article-title":"The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality","volume":"70","author":"Wang","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2021021208580891800_dkaa446-B5","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"2021021208580891800_dkaa446-B6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"2021021208580891800_dkaa446-B7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1086\/520980","article-title":"Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis","volume":"45","author":"Pappas","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B8","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1056\/NEJMoa066906","article-title":"Anidulafungin versus fluconazole for invasive candidiasis","volume":"356","author":"Reboli","year":"2007","journal-title":"N Engl J Med"},{"key":"2021021208580891800_dkaa446-B9","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1086\/598933","article-title":"A multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis","volume":"48","author":"Betts","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B10","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1093\/cid\/ciy827","article-title":"Isavuconazole versus caspofungin in the treatment of candidemia and other invasive Candida infections: the ACTIVE trial","volume":"68","author":"Kullberg","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B11","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1086\/603585","article-title":"Echinocandin-based initial therapy in fungemic patients with cancer: a focus on recent guidelines of the Infectious Diseases Society of America","volume":"49","author":"Kontoyiannis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B12","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/jac\/dkx423","article-title":"Impact of unresolved neutropenia in patients with neutropenia and invasive aspergillosis: a post hoc analysis of the SECURE trial","volume":"73","author":"Kontoyiannis","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2021021208580891800_dkaa446-B13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"key":"2021021208580891800_dkaa446-B14","doi-asserted-by":"crossref","first-page":"e1\u201350","DOI":"10.1093\/cid\/civ1194","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1469-0691.12038","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures","volume":"18","author":"Cuenca-Estrella","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021021208580891800_dkaa446-B16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bjid.2013.02.001","article-title":"Brazilian guidelines for the management of candidiasis\u2014a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical","volume":"17","author":"Colombo","year":"2013","journal-title":"Brazilian J Infect Dis"},{"key":"2021021208580891800_dkaa446-B17","doi-asserted-by":"crossref","first-page":"e122\u201350","DOI":"10.1155\/2010\/357076","article-title":"Canadian clinical practice guidelines for invasive candidiasis in adults","volume":"21","author":"Bow","year":"2010","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"2021021208580891800_dkaa446-B18","first-page":"22","article-title":"Invasive candidiasis in the neutropenic patient","volume":"30 Suppl 1","author":"Fort\u00fan","year":"2017","journal-title":"Rev Esp Quimioter"},{"key":"2021021208580891800_dkaa446-B19","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1086\/428669","article-title":"Candidemia in patients with cancer: are persistent neutropenia and severity of illness score still relevant?","volume":"40","author":"Nucci","year":"2005","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B20","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/382874","article-title":"Management of central venous catheters in patients with cancer and candidemia","volume":"38","author":"Raad","year":"2004","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/1469-0691.12041","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT)","volume":"18 Suppl 7","author":"Ullmann","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2021021208580891800_dkaa446-B22","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/cid\/ciy774","article-title":"Clinical infectious diseases considerations for clinical trials of Staphylococcus aureus bloodstream infection in adults","volume":"68","author":"Holland","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2021021208580891800_dkaa446-B23","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1002\/cncr.24507","article-title":"Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007","volume":"115","author":"Sipsas","year":"2009","journal-title":"Cancer"},{"key":"2021021208580891800_dkaa446-B24","doi-asserted-by":"crossref","first-page":"S474","DOI":"10.1093\/infdis\/jix130","article-title":"Novel agents and drug targets to meet the challenges of resistant fungi","volume":"216 Suppl 3","author":"McCarthy","year":"2017","journal-title":"J Infect Dis"},{"key":"2021021208580891800_dkaa446-B25","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/21505594.2016.1226721","article-title":"Antifungal stewardship considerations for adults and pediatrics","volume":"8","author":"Hamdy","year":"2017","journal-title":"Virulence"},{"key":"2021021208580891800_dkaa446-B26","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1080\/10428194.2019.1590570","article-title":"Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program","volume":"60","author":"Paige","year":"2019","journal-title":"Leuk Lymphoma"},{"key":"2021021208580891800_dkaa446-B27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/10428194.2017.1365861","article-title":"Acute myeloid leukemia and the infectious diseases consultant","volume":"59","author":"Mulanovich","year":"2018","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/543\/36241110\/dkaa446.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/76\/3\/543\/36241110\/dkaa446.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,13]],"date-time":"2021-02-13T00:21:16Z","timestamp":1613175676000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/76\/3\/543\/5956385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,5]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,11,5]]},"published-print":{"date-parts":[[2021,2,11]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkaa446","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"type":"print","value":"0305-7453"},{"type":"electronic","value":"1460-2091"}],"subject":[],"published-other":{"date-parts":[[2021,3,1]]},"published":{"date-parts":[[2020,11,5]]}}}